Karen Scanlon Henry

Karen Henry practices at Sylvester Comprehensive Cancer Center in Miami, Florida, part of University of Miami.

Karen Henry's NPI, 1588651392, was assigned on October 6, 2005. Karen Henry holds Florida license ARNP 1527932.

Karen Henry's primary practice is Sylvester Comprehensive Cancer Center, at 1475 Nw 12th Ave, Miami, FL 33136.

Karen Henry's primary practice is Sylvester Comprehensive Cancer Center in Miami, Florida, part of University of Miami. Karen Henry is also affiliated with Baptist Health Baptist Hospital. The medical group on file is University of Miami Health System.

Dmand AI tracks the electronic health record (EHR) system at each site where Karen Henry practices, 2 sites in all. Vendor and product names are available with a free account.

Family is Karen Henry's primary specialty in the NPI Registry, under taxonomy code 363LF0000X. Karen Henry is licensed in Florida.

Dmand AI lists depression and tobacco use among the conditions Karen Henry treats.

CMS data shows 163 Medicare services from Karen Henry across 2 procedure codes in 2024, all of them office visits, for 72 Medicare patients. Medicare paid $9,239 for them. Every service was in an office.

CMS counts 72 Medicare patients who saw Karen Henry in 2024. The largest group is 65 to 74, with 37 patients. 75% of them have cancer, and 75% have high cholesterol. 43% are also on Medicaid. Their average risk score is 2.25, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Karen Henry's median patient age at 73, with 62% women.

In 2024, Karen Henry wrote 509 Medicare Part D claims for 138 patients. 75% of them were for generic drugs. CMS names the drug for 240 of them, across 10 drugs with 11 or more claims each, at $1,072,434 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Karen Henry for performance year 2024, reported as part of a group. Karen Henry accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Karen Henry as offering telehealth.

CMS Open Payments shows 54 general payments to Karen Henry from 17 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 90% of the total. Pfizer Inc. paid the most, $286.